CalRexin™:568 research reagent independently validated

Written By Nina Chalmers

Apop Biosciences is pleased to announce that our CalRexin™:568 research reagent for the detection of apoptosis has been independently validated for FACS by Crux Biolabs (VIC). Crux Biolabs is a leading Australian bioanalytical lab. CalRexin™:568 is for use in live cell assays to image events leading to apoptosis.

To obtain the full report, please get in touch with us at info@apopbiosciences.com

Nina Chalmers
Previous

Peter Wookey presenting at JAM

Next

Apop Biosciences distributors for Australia & NZ and the USA